SkinBioTherapeutics Plc is a life science company, which focuses on skin health. It offers SkinBiotix, a technology platform based on microbiome research which comprises extracts of probiotic bacteria for skin application. The technology targets the following skin healthcare sectors: cosmetics, infection control, and eczema. The company was founded on June 10, 2015 is headquartered in Newcastle upon Tyne, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company